IP Verse

Amring Pharmaceuticals Inc V. Rubicon Research Private Ltd. - 2:23-cv-03494

Explore the details of the Amring Pharmaceuticals Inc V. Rubicon Research Private Ltd. case under case number 2:23-cv-03494 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
2:23-cv-03494
Filing Date
Jun 28, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
RUBICON RESEARCH PRIVATE LTD. -
AMRING PHARMACEUTICALS INC -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 28, 2023Corporate Disclosure Statement by AMRING PHARMACEUTICALS INC identifying Nordic Group B.V. as Corporate Parent.. (PANZER, DOUGLAS) (Entered: 06/28/2023)PACER Document
Jun 28, 2023COMPLAINT against RUBICON RESEARCH PRIVATE LIMITED ( Filing and Admin fee $ 402 receipt number ANJDC-14420553) with JURY DEMAND, filed by AMRING PHARMACEUTICALS INC. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit US Patent No 7947739, # 3 Exhibit US Patent No 8022106, # 4 Exhibit US Patent No 8273795, # 5 Exhibit US Patent No 8487005, # 6 Exhibit US Patent No 8791160, # 7 Exhibit US Patent No 8809394, # 8 Exhibit US Patent No 8957113, # 9 Exhibit US Patent No 9060939)(PANZER, DOUGLAS) (Entered: 06/28/2023)PACER Document
Jun 29, 2023SUMMONS ISSUED as to RUBICON RESEARCH PRIVATE LTD.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jd, ) (Entered: 06/29/2023)PACER Document
Jun 29, 2023AO120 Patent/Trademark Form filed. (Attachments: # 1 Complaint, # 2 Civil Cover Sheet, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D, # 7 Exhibit E, # 8 Exhibit F, # 9 Exhibit G, # 10 Exhibit H) (jd, ) (Entered: 06/29/2023)PACER Document
Sep 25, 2023WAIVER OF SERVICE Returned Executed by AMRING PHARMACEUTICALS INC. RUBICON RESEARCH PRIVATE LTD. waiver sent on 9/22/2023, answer due 11/21/2023. (PANZER, DOUGLAS) (Entered: 09/25/2023)PACER Document
Sep 27, 2023NOTICE of Appearance by KAAN EKINER on behalf of RUBICON RESEARCH PRIVATE LTD. (EKINER, KAAN) (Entered: 09/27/2023)PACER Document
Nov 16, 2023STIPULATION regarding the deadline by which Defendant must answer, move, or otherwise respond to the Complaint by RUBICON RESEARCH PRIVATE LTD.. (EKINER, KAAN) (Entered: 11/16/2023)PACER Document
Nov 27, 2023STIPULATION AND ORDER setting Defendant RUBICON RESEARCH PRIVATE LTD. deadline must answer, move, or otherwise respond to the Complaint by 12/21/2023. Signed by Magistrate Judge James B. Clark on 11/27/2023. (jd, ) (Entered: 11/27/2023)PACER Document
Dec 19, 2023STIPULATION and Proposed Order for Extension of Time for Defendant to Respond to Complaint by RUBICON RESEARCH PRIVATE LTD.. (EKINER, KAAN) (Entered: 12/19/2023)PACER Document
Dec 21, 2023STIPULATION AND ORDER for Extension of Time to 2/20/2024 for Defendant to Respond to Complaint. Signed by Magistrate Judge James B. Clark on 12/21/2023. (wh) (Entered: 12/21/2023)PACER Document
Dec 22, 2023STIPULATION of Dismissal WITHOUT PREJUDICE AND [PROPOSED] ORDER FOR DISMISSAL by AMRING PHARMACEUTICALS INC. (PANZER, DOUGLAS) (Entered: 12/22/2023)PACER Document
Dec 27, 2023STIPULATION AND ORDER OF DISMISSAL without Prejudice. Signed by Judge Susan D. Wigenton on 12/27/2023. (jd, ) (Entered: 12/27/2023)PACER Document
Jun 28, 2023Case Assigned to Magistrate Judge James B. Clark. (ak, )PACER Document
Dec 21, 2023Answer Due Deadline Update - The answer due date has been set for 2/20/2024 as to Defendant RUBICON RESEARCH PRIVATE LTD. pursuant to the 10 Stipulation and Order. (wh)PACER Document